source
- FDA nominee Heidi Overton pledges faster, more efficient regulation to keep pace with ChinaDuring a Senate hearing, Heidi Overton was confirmed as the nominee to lead the U.S. Food and Drug Administration. She outlined her priorities for the agency. Overton said the FDA must move faster…
- Merck's $1.3B EyeBio investment yields first ophthalmology successMerck's strategic move to re-enter ophthalmology has begun to show results after its 2024 acquisition of EyeBio. The company committed $1.3 billion upfront for EyeBio, aiming to broaden its pipeli…